195 related articles for article (PubMed ID: 14645192)
1. Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of beta-cell dysfunction?
Maliqueo M; Atwater I; Lahsen R; Pérez-Bravo F; Angel B; Sir-Petermann T
Hum Reprod; 2003 Dec; 18(12):2683-8. PubMed ID: 14645192
[TBL] [Abstract][Full Text] [Related]
2. Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome.
Panidis D; Macut D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Spanos N; Petakov M; Bjekic J; Damjanovic S
Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):99-105. PubMed ID: 16460870
[TBL] [Abstract][Full Text] [Related]
3. The entero-insular axis in polycystic ovarian syndrome.
Gama R; Norris F; Wright J; Morgan L; Hampton S; Watkins S; Marks V
Ann Clin Biochem; 1996 May; 33 ( Pt 3)():190-5. PubMed ID: 8791980
[TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin.
Conway GS; Clark PM; Wong D
Clin Endocrinol (Oxf); 1993 Feb; 38(2):219-22. PubMed ID: 8435903
[TBL] [Abstract][Full Text] [Related]
5. Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome.
Vrbíková J; Bendlová B; Hill M; Vanková M; Vondra K; Stárka L
Diabetes Care; 2002 Jul; 25(7):1217-22. PubMed ID: 12087022
[TBL] [Abstract][Full Text] [Related]
6. Preserved insulin sensitivity and {beta}-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome.
Gennarelli G; Rovei V; Novi RF; Holte J; Bongioanni F; Revelli A; Pacini G; Cavallo-Perin P; Massobrio M
J Clin Endocrinol Metab; 2005 Jun; 90(6):3381-6. PubMed ID: 15755857
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.
Ciampelli M; Fulghesu AM; Cucinelli F; Pavone V; Caruso A; Mancuso S; Lanzone A
Hum Reprod; 1997 Sep; 12(9):1897-901. PubMed ID: 9363702
[TBL] [Abstract][Full Text] [Related]
8. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.
Escobar-Morreale HF; Botella-Carretero JI; Villuendas G; Sancho J; San Millán JL
J Clin Endocrinol Metab; 2004 Feb; 89(2):806-11. PubMed ID: 14764799
[TBL] [Abstract][Full Text] [Related]
10. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
11. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
12. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
Legro RS; Finegood D; Dunaif A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?
Gennarelli G; Holte J; Wide L; Berne C; Lithell H
Hum Reprod; 1998 Mar; 13(3):535-41. PubMed ID: 9572406
[TBL] [Abstract][Full Text] [Related]
14. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.
Dunaif A; Finegood DT
J Clin Endocrinol Metab; 1996 Mar; 81(3):942-7. PubMed ID: 8772555
[TBL] [Abstract][Full Text] [Related]
15. Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS)--the effect of metformin treatment.
Kruszyńska A; Słowińska-Srzednicka J; Jeske W; Zgliczyński W
Endokrynol Pol; 2014; 65(1):2-10. PubMed ID: 24549596
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
18. The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function.
Weber RF; Pache TD; Jacobs ML; Docter R; Loriaux DL; Fauser BC; Birkenhäger JC
Clin Endocrinol (Oxf); 1993 Mar; 38(3):295-300. PubMed ID: 8458101
[TBL] [Abstract][Full Text] [Related]
19. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements.
Spritzer PM; Poy M; Wiltgen D; Mylius LS; Capp E
Hum Reprod; 2001 Jul; 16(7):1340-6. PubMed ID: 11425810
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
